Is determination of angiogenic activity in human tumours clinically useful? Arbiter

European Journal of Cancer

Volumn 34, Issue 5, 1998, Pages 615-618

  Gasparini, G ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006012230     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10042-9     Document Type: Article

References (45)

1. Gasparini G. Angiogenesis research up to 1996. A commentary on the state of the art and suggestions for future studies. Eur J Cancer 1996, 32A, 2379-2385.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995, 1, 27-31.
3. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996, 32A, 2474-2484.
4. Gasparini G. Antiangiogenic drugs as a novel anticancer therapeutic strategy. Which are the more promising agents? What are the clinical developments and indications? Critical Rev Oncol Hematol 1997, 26, 147-162.
5. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 1993, 53, 2178-2187.
6. Zhang H-T, Craft P, Scott PAE, et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 1995, 87, 213-219.
7. Gasparini G. Angiogenesis in endocrine-related cancers. Endocrine-Rel Cancers 1997, 4, 423-445.
8. Gasparini G, Harris AL. In Klijn JGM, eds. ESO Scientific Updates, Vol. 1. Prognostic and Predictive Value of p53. Amsterdam, Elsevier Science, 1997, 115-130.
9. Gasparini G, Barbareschi M, Boracchi P, et al. 67-Kda lamininreceptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer. Int J Cancer 1995,60, 604-610.
10. Brooks PC. Role of integrins in angiogenesis. Eur J Cancer 1996, 32A, 2423-2429.
11. Hanahan D, Folkman J. Patterns of emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353-364.
12. Gasparini G. Angiogenesis in preneoplastic and neoplastic lesions. Cancer J 1995, 8, 91-93.
13. Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T. Clinical significance of the determination of angiogenic factors. Eur J Cancer 1996, 32A, 2513-2519.
14. Gasparini G. Clinical significance of the determination of angiogenesis in human breast cancer: update of the biological background and overview of the Vicenza studies. Eur J Cancer 1996, 32A, 2485-2493.
15. Gasparini G. Angiogenesis in breast cancer: role in biology, tumor progression and prognosis. In Bowcock A, ed. Breast Cancer. Totowa, New Jersey, U.S.A., Humana Press.
16. Hall NR, Fish DE, Hunt N, Goldin RD, Gullino PJ, Monson JRT. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1992, 1, 223-229.
17. Khanuja PS, Gimotty P, Fregene T, George J, Pienta KJ. Angiogenesis quantitation as a prognostic factor for primary breast carcinoma 2 cms or less. In Salmon SE, ed. Adjuvant Therapy of Cancer VII. Philadelphia, Pennsylvania, U.S.A. JB Lippincott, 1993, 226-232.
18. Goulding H, Rashid NA, Robertson F, et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 1995, 26, 1196-1200.
19. Axelsson K, Ljung B-ME, More II DH, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Nad Cancer Inst 1995, 87, 997-1008.
20. Morphopoulos G, Pearson M, Ryder WDJ, Howell A, Harris M. Tumour angiogenesis as a prognostic marker in infiltrating loubular carcinoma of the breast. J Pathol 1996, 180, 44-49.
21. Sterns EE, SenGupta S, Zee B. Macromolecular interstitital clearance, tumour vascularity, other prognostic factors and breast cancer survival. Breast Cancer Res Treat 1997, 42, 113-120.
22. Van Hoef MEHN, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993, 29A, 1141-1145.
23. Siitonen SM, Haapasalo HK, Rantala IS, Heiin HJ, Isola JJ. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Modern Pathol 1995, 8, 745-752.
24. Costello P, McCann A, Carney DN, Dervan PA. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 1995, 26, 1181-1184.
25. Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in nodenegative breast cancer patients. J Natl Cancer Inst 1993, 85, 1206-1219.
26. Walker RA. Angiogenesis and breast cancer prognosis-a continuous issue. J Pathol 1996, 180, 6-7.
27. Page DL, Jensen RA. Angiogenesis in human breast carcinoma: what is the question? Human Pathol 1995, 26, 1173-1174.
28. Pezzella F, Di Bacco A, Andreola S, Nicholson AG, Pastorino U, Harris AL. Angiogenesis in primary lung cancer and lung secondaries. Eur J Cancer 1996, 32A, 2494-2500.
29. Chung YS, Maeda K, Sowa M. Prognostic value of angiogenesis in gastro-intestinal tumours. Eur J Cancer 1996, 32A, 2501-2505.
30. Weidner N. Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer 1996, 32A, 2506-2512.
31. Gasparini G, Barbareschi M, Boracchi P, et al. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. Cancer J Sei Am 1995, 1, 131-141.
32. Gasparini G, Fox SB, Verderio P, et al. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. Clin Cancer Res 1996, 2, 1191-1198.
33. Macaulay VM, Fox SB, Zhang H, et al. Breast cancer angiogenesis and tamoxifen resistance. Endocrine-Rel Cancer 1995, 2, 97-103.
34. Gasparini G, Presta M. Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation. Ann Oncol 1996, 7, 441-444.
35. Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 1996, 73, 931-934.
36. Fontanini G, Vignati S, Lucchi M, et al. Microvessel count, neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 1997, 75, 1295-1301.
37. Li VW, Folkerth RD, Watanabe H, et al. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 1994, 344, 82-86.
38. Hildenbrand R, Dilger I, Horlin A, Stutte HJ. Urokinase and macrophages in tumour angiogenesis. Br J Cancer 1995, 72, 818-823.
39. McCulloch P, Choy A, Martin L. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery. Lancet 1995, 346, 1334-1335.
40. Grossfeld GD, Ginsberg DA, Stein JP, et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 1997,89, 219-227.
41. Barbareschi M, Weidner N, Gasparini G, et al. Microvessel density quantification in breast carcinomas: assessment by light microscopy vs a computer-aided image analysis system. Appl Immunohistochem 1995, 3, 75-84.
42. Fox SB, Leek RD, Weekes MP, et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995, 177, 275-283.
43. Toi M, Gion M, Biganzoli E, et al. Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications. Angiogenesis 1997, 1, 71-83.
44. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarker FH, Cheresh DA. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995, 96, 1815-1822.
45. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nature Med 1997, 3, 780-782.